Evaluation of the protective activity of deferiprone, an aluminium chelator, on aluminium-induced developmental toxicity in mice

Teratology

Volumn 62, Issue 2, 2000, Pages 86-92

  Albina, M Luisa ^a   Bellés, Montserrat ^a   Sanchez, Domenec J ^a   Domingo, Jose L ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM NITRATE; CHELATING AGENT; DEFERIPRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CESAREAN SECTION; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY; WEIGHT GAIN;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, ORAL; ALUMINUM; ANIMALS; BODY WEIGHT; BONE AND BONES; FEMALE; FETAL GROWTH RETARDATION; IRON CHELATING AGENTS; MALE; MICE; ORGAN SIZE; PYRIDONES; TIME FACTORS;

ANIMALIA;

EID: 0033863150     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9926(200008)62:2<86::AID-TERA4>3.0.CO;2-P     Document Type: Article

References (37)

1. Albina ML, Bellés M, Sanchez DJ, Domingo JL. 1999. Prevention by desferrioxamine of aluminum-induced maternal and developmental toxic effects in mice. Trace Elem Electrolytes 16:192-198.
2. Alfrey AC. 1993. Aluminum and renal disease. In: Bourke E, Mallick NP, Pollak VE, editors. Moving points in nephrology. Basel: S Karger. p 110-124.
3. Alfrey AC. 1997. Aluminum metabolism. In: Zatta PF, Alfrey AC, editors. Aluminum toxicity in infants' health and disease. Singapore: World Scientific Publications, p 54-64.
4. Andreoli SP, Bergstein JM, Sherrard DJ. 1984. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310:1079-1084.
5. Bellés M, Sanchez DJ, Gomez M, Corbella J, Domingo JL. 1998. Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer disease. Alzheimer Dis Assoc Disord 12:83-87.
6. Bellés M, Albina ML, Sanchez DJ, Domingo JL. 1999. Lack of protective effects of dietary silicon on aluminum-induced maternal and developmental toxicity in mice. Pharmacol Toxicol 85:1-6.
7. Bernuzzi V, Desor D, Lehr PR. 1989. Developmental alterations in offspring of female rats orally intoxicated by aluminum chloride or lactate during gestation. Teratology 40:21-27.
8. Borak J, Wise JP Sr. 1998. Does aluminum exposure of pregnant animals lead to accumulation in mothers or their offspring? Teratology 57:127-139.
9. Bosque MA, Domingo JL, Llobet JM, Corbella J. 1993. Variability in the embryotoxicity and fetotoxicity of vanadate with the day of exposure. Vet Hum Toxicol 35:1-3.
10. Colomina MT, Gomez M, Domingo JL, Llobet JM, Corbella J. 1992. Concurrent ingestion of lactate and aluminum can result in developmental toxicity in mice. Res Commun Chem Pathol Pharmacol 77:95-106.
11. Colomina MT, Domingo JL, Llobet JM, Corbella J. 1996. Effect of day of exposure on the developmental toxicity of manganese in mice. Vet Hum Toxicol 38:7-9.
12. Domingo JL. 1995a. Reproductive and developmental toxicity of aluminum: a review. Neurotoxicol Teratol 17:515-521.
13. Domingo JL. 1995b. Prevention by chelating agents of metal-induced developmental toxicity. Reprod Toxicol 9:105-113.
14. Domingo JL. 1996. Adverse effects of aluminum-chelating compounds for clinical use. Adverse Drug React Toxicol Rev 15:145-165.
15. Domingo JL. 1998. Developmental toxicity of metal chelating agents. Reprod Toxicol 12:499-510.
16. Domingo JL, Gomez M, Bosque MA, Corbella J. 1989. Lack of teratogenicity of aluminum hydroxide in mice. Life Sci 45:243-247.
17. Domingo JL, Gomez M, Llobet JM, Corbella J. 1991a. Influence of some dietary constituents on aluminum absorption and retention in rats. Kidney Int 39:598-601.
18. Domingo JL, Gomez M, Llobet JM, Richart C. 1991b. Effect of ascorbic acid on gastrointestinal aluminum absorption. Lancet 338:1467.
19. Domingo JL, Bosque MA, Luna M, Corbella J. 1993. Prevention by Tiron (sodium 4,5-dihydroxybenzene-1,3-disulfonate) of vanadate-induced developmental toxicity in mice. Teratology 48:133-138.
20. Exley C, Burgess E, Day JP, Jeffery EH, Melethil S, Yokel RA. 1996. Aluminum toxicokinetics. J Toxicol Environ Health 48: 569-584.
21. Gilbert-Barness E, Barness LA, Wolff J, Harding C. 1998. Aluminum toxicity. Arch Pediatr Adolesc Med 152:511-512.
22. Golub MS, Domingo JL. 1996. What we know and what we need to know about developmental aluminum toxicity. J Toxicol Environ Health 48:585-597.
23. Golub MS, Domingo JL. 1998. Fetal aluminum accumulation [letter]. Teratology 58:225-226.
24. Golub MS, Gershwin ME, Donald JM, Negri S, Keen CL. 1987. Maternal and developmental toxicity of chronic aluminum exposure in mice. Fundam Appl Toxicol 8:346-357.
25. Gomez M, Bosque MA, Domingo JL, Llobet JM, Corbella J. 1990. Evaluation of the maternal and developmental toxicity of aluminum from high doses of aluminum hydroxide in rats. Vet Hum Toxicol 32:545-548.
26. Gomez M, Domingo JL, Llobet JM. 1991. Developmental toxicity evaluation of oral aluminum in rats: influence of citrate. Neurotoxicol Teratol 13:323-328.
27. Kontoghiorghes GJ. 1995. Comparative efficacy and toxicity of desferrioxamine, deferiprone, and other iron and aluminum chelating drugs. Toxicol Lett 80:1-18.
28. Llobet JM, Domingo JL, Gomez M, Tomas JM, Corbella J. 1987. Acute toxicity studies of aluminum compounds: antidotal efficacy of several chelating agents. Pharmacol Toxicol 60:280-283.
29. Muller G, Bernuzzi V, Desor D, Hutin MF, Burnel D, Lehr PR. 1990. Developmental alterations in offspring of female rats orally intoxicated by aluminum lactate at different gestation periods. Teratology 42:253-261.
30. Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. 1998. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 339:417-423.
31. Partridge NA, Regnier FE, White JL, Hem SL. 1989. Influence of dietary constituents on intestinal absorption of aluminum. Kidney Int 35:1413-1417.
32. Paternain JL, Domingo JL, Llobet JM, Corbella J. 1988. Embryotoxic and teratogenic effects of Al nitrate in rats upon oral administration. Teratology 38:253-257.
33. Staples RE, Schnell VL. 1968. Refinements in rapid clearing technique in the KOH-alizarin red S method for fetal bone. Stain Technol 43:61-63.
34. Weberg R, Berstad A, Ladehaug B, Thomassen Y. 1986. Are aluminum containing antacids during pregnancy safe? Acta Pharmacol Toxicol 59[suppl]:63-65.
35. Wide M. 1985. Lead exposure on critical days of fetal life affects fertility in the female mouse. Teratology 32:375-380.
36. Wilson JG. 1965. Embryological considerations in teratology. In: Wilson JG, Warkany J, editors. Teratology: principles and techniques. Chicago: University of Chicago Press. p 251-277.
37. Yokel RA, Ackrill P, Burgess E, Day JP, Domingo JL, Flaten TP, Savory J. 1996. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs. J Toxicol Environ Health 48:667-683.